Infinity to Stop Development on Rheumatoid Arthritis Treatment

Infinity Pharmaceuticals said it will discontinue developing its rheumatoid-arthritis treatment duvelisib after the drug didn’t meet its goal in a clinical trial.



from WSJ.com: US Business http://ift.tt/1w2LqV3

via IFTTT